Designing Effective Physician Advisory Board Meetings
|Physician advisory board meetings are quite common in our industry — and, done well, they can be very helpful. Convening a face-to-face meeting with a group of expert physicians in a given therapeutic area benefits biopharma companies in several ways. Some of these include: verifying assumptions about unmet medical needs in the market; gaining insight… Read the full article…|
Rare Diseases: Abandon Everything You Think You Know
|“Overcoming the hurdles has built a great faith in me that things can be done to help people with rare diseases. It will drive my optimism forever and my belief in achieving things that seem impossible.” —Henri Termeer, CEO of Genzyme,who launched the first lifesaving treatment, Ceredase, for Gaucher Disease I am and will always… Read the full article…|
Does Boston Biotech Have a Career Navigation Problem?
|For those of us who have been in the industry since pre-DRG days, and have the wisdom and experience across the industry, there are many opportunities to mentor and network with today’s emerging generation of biotech executives. Now and then, we get the chance to speak with those who truly are the future generation –… Read the full article…|
Four Essential Market Assessment Questions
|What follows are excerpts from a conversation among NemetzGroup team members regarding market assessment approaches. Specifically, we talked about the levels and types of market assessments needed to answer fundamental development and financial opportunity questions. The framework we tend to follow is shown below. For today’s newsletter, we will focus on the first column —… Read the full article…|
Enjoy Summer, but Plan for the Fall
|In my view, September is even worse than January since that return to work comes after the holidays when almost everyone has taken some time off. And, of course, January begins with New Year’s parties, resolutions, start fresh budgets, and a new set of annual objectives, plus a full calendar year to complete them. September… Read the full article…|
The Sound of Silos
|We have all heard about it; some of us have lived it firsthand. A vibrant, new start-up comes to life with energy and purpose. Everyone knows one another; everyone works together towards a common goal. Communication happens on the fly, informally, at all hours of the day and night. It’s fast and it’s fun —… Read the full article…|
When Did Process Become a Dirty Word?
|We live in a competitive, fast-moving industry. I know I say that every month, but that reality must impact how we think about how to achieve. The word cloud below is an output of an interactive session with my team where we were discussing the reality of our clients’ complex worlds in biopharma today. Furthermore,… Read the full article…|
21st Century Commercialization – More than a Point in Time!
|Is it just me, or has commercialization, as a term, taken on more prominence in our biopharma world of late? It seems that every day we read more about it, hear more about it, and yes, talk more about it than ever before. But what does the term really mean? Does it create a “stigma,”… Read the full article…|
Power to the People
|Each month, as I ponder possible topics for this e-conversation, I find myself struggling with the same challenge: So many things to talk about; so hard to pick just one! When I decide to set aside topics within our core area of commercialization, you know I must be feeling a pressing need to speak to… Read the full article…|
Are You Getting the Most Out of Your Consultants?
|It is always risky to read one HBR article and then assume you can apply it to every other work scenario in front of you. But here we go anyway. In their article, HR Goes Agile, authors Peter Cappelli and Anna Tavis explain how the concepts of “agile development from the tech industry” have… Read the full article…|